Red/yellow brain pigment linked to Parkinson’s disease: Study
This story discusses a study by Team Chen that found that people with Parkinson’s disease have higher than normal levels of a nerve cell-damaging red/yellow pigment called pheomelanin in their substantia nigra, the area of the brain that’s mainly affected by the neurodegenerative disease.
New study puts gut microbiome at the center of Parkinson’s disease pathogenesis
Science Daily covers a study by Team Liddle that says that the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease.
Metagenomics of Parkinson disease implicates the gut microbiome in multiple disease mechanisms
This podcast episode features Haydeh Payami from Team Liddle and discusses how the gut microbiome may play a role in Parkinson's disease according to metagenomics.
Exclusive: Google Cofounder Sergey Brin Has Quietly Donated More Than $1 Billion Toward Parkinson’s Disease
Forbes Magazine spotlights the ASAP initiative and the collective effort to accelerate the pace of discovery and inform the path to a cure for Parkinson's disease.
GP2 Cohort Dashboard Now Includes New Ancestry Categories
The updated GP2 Cohort dashboard now includes additional ancestry information across cohort samples that have already been processed and shared with the AMP® PD platform.
Congratulations to the 2022 COSA Prize Recipients
ASAP’s second annual Celebration of Scientific Achievement (COSA) showcased the outstanding contributions of young investigators across our Collaborative Research Network (CRN). This year’s event attracted over 400 participants, with 140 abstracts being showcased from across the network.